Netherlands

Netherlands

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.34 (0.22 - 0.47) 2016 Survey/reported Koopsen J et al, 2019
0.2 (0.10 - 0.40) 2007 Survey/reported Hahne SJM et al, 2012
0.09 (0.07 - 0.11) 2015 Modelled WHO
0.3 (0.10 - 0.40) 2016 Modelled Razavi-Shearer et al, 2018
0.2 (0.10 - 0.40) 2007 Survey/reported ECDC
0.4 (0.39 - 0.41) 2013 Modelled Schweitzer et al, 2015
0.87 (0.70 - 1.04) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.96 (0.78 - 1.14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.79 - 1.16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.82 - 1.17) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.84 - 1.19) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.84 - 1.18) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.83 - 1.18) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.82 - 1.18) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.82 - 1.18) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.18) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.81 - 1.17) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.16) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.81 - 1.15) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.81 - 1.15) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.82 - 1.16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.84 - 1.18) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.84 - 1.20) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.85 - 1.21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.85 - 1.21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.84 - 1.20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.84 - 1.19) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.19) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.83 - 1.19) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.84 - 1.20) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.84 - 1.20) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.84 - 1.21) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.85 - 1.23) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.85 - 1.24) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.77 - 1.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.04 (0.03 - 0.05) 2015 Modelled WHO
0.06 (0.04 - 0.07) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.09 (0.06 - 0.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.07 - 0.13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.08 - 0.16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.09 - 0.19) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.27) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.21 - 0.42) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.29 - 0.59) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.35 - 0.73) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.38 - 0.79) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.79) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.78) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.77) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.39 - 0.76) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.39 - 0.77) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.40 - 0.78) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.42 - 0.83) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.44 - 0.88) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.46 - 0.94) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.47 - 0.97) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.48 - 0.97) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.47 - 0.96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.46 - 0.95) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.45 - 0.95) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.45 - 0.96) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.45 - 0.94) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.45 - 0.94) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.46 - 0.95) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.47 - 0.97) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.48 - 0.99) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.07 - 0.09) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.3 (0.30 - 0.40) 2016 Modelled ECDC
0.3 (0.30 - 0.40) 2006 Survey/reported Op de Coul EL et al, 2011
0.3 (0.30 - 0.40) 2007 Survey/reported Op de Coul EL et al, 2011
0.4 (0.40 - 0.40) 2008 Survey/reported Op de Coul EL et al, 2011
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
6.3 2017 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
0.48 2017 Survey/reported ECDC Monitoring Report
0.83 2017 Survey/reported ECDC Monitoring Report
0.83 2017 Survey/reported ECDC
0.48 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
47,000 (25,000 - 68,000) 2016 Modelled Razavi-Shearer et al, 2018
148,649 (120,605 - 178,493) 2019 Modelled IHME, GBD 2019 (accessed 2020)
152,624 (123,734 - 182,491) 2019 Modelled IHME, GBD 2019 (accessed 2022)
155,581 (126,408 - 184,306) 2018 Modelled IHME, GBD 2019 (accessed 2022)
157,343 (126,391 - 186,536) 2017 Modelled IHME, GBD 2019 (accessed 2022)
159,111 (131,213 - 187,383) 2016 Modelled IHME, GBD 2019 (accessed 2022)
160,262 (133,542 - 188,997) 2015 Modelled IHME, GBD 2019 (accessed 2022)
159,693 (132,510 - 187,427) 2014 Modelled IHME, GBD 2019 (accessed 2022)
158,721 (131,106 - 186,565) 2013 Modelled IHME, GBD 2019 (accessed 2022)
157,499 (129,373 - 185,622) 2012 Modelled IHME, GBD 2019 (accessed 2022)
156,097 (128,556 - 184,578) 2011 Modelled IHME, GBD 2019 (accessed 2022)
154,603 (125,453 - 183,503) 2010 Modelled IHME, GBD 2019 (accessed 2022)
153,078 (125,682 - 181,636) 2009 Modelled IHME, GBD 2019 (accessed 2022)
151,600 (124,918 - 179,503) 2008 Modelled IHME, GBD 2019 (accessed 2022)
150,296 (124,446 - 177,663) 2007 Modelled IHME, GBD 2019 (accessed 2022)
149,265 (123,267 - 176,261) 2006 Modelled IHME, GBD 2019 (accessed 2022)
148,596 (122,491 - 176,179) 2005 Modelled IHME, GBD 2019 (accessed 2022)
148,716 (123,103 - 175,520) 2004 Modelled IHME, GBD 2019 (accessed 2022)
149,633 (124,088 - 176,182) 2003 Modelled IHME, GBD 2019 (accessed 2022)
150,811 (125,346 - 177,432) 2002 Modelled IHME, GBD 2019 (accessed 2022)
151,712 (126,365 - 179,249) 2001 Modelled IHME, GBD 2019 (accessed 2022)
151,840 (125,641 - 180,051) 2000 Modelled IHME, GBD 2019 (accessed 2022)
150,852 (125,005 - 179,030) 1999 Modelled IHME, GBD 2019 (accessed 2022)
149,097 (123,373 - 175,760) 1998 Modelled IHME, GBD 2019 (accessed 2022)
147,141 (121,653 - 173,728) 1997 Modelled IHME, GBD 2019 (accessed 2022)
145,536 (120,778 - 171,945) 1996 Modelled IHME, GBD 2019 (accessed 2022)
144,789 (119,933 - 171,741) 1995 Modelled IHME, GBD 2019 (accessed 2022)
144,616 (119,750 - 171,238) 1994 Modelled IHME, GBD 2019 (accessed 2022)
144,413 (119,320 - 171,164) 1993 Modelled IHME, GBD 2019 (accessed 2022)
144,204 (119,347 - 170,707) 1992 Modelled IHME, GBD 2019 (accessed 2022)
144,018 (119,047 - 171,867) 1991 Modelled IHME, GBD 2019 (accessed 2022)
143,933 (118,063 - 171,978) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.65 (1.27 - 2.11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.29 (0.99 - 1.67) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.02 - 1.70) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.35 (1.03 - 1.75) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.42 (1.09 - 1.84) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.46 (1.12 - 1.89) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.4 (1.07 - 1.82) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.49 (1.15 - 1.93) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.48 (1.14 - 1.93) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.52 (1.17 - 1.96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.57 (1.21 - 2.02) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.24 - 2.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.26 - 2.11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.29 - 2.18) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.34 - 2.26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.28 - 2.16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.63 (1.25 - 2.11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.24 - 2.10) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.24 - 2.05) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (1.23 - 2.05) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.24 - 2.04) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.25 - 2.05) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.24 - 2.05) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.25 - 2.06) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.56 (1.20 - 1.99) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.58 (1.22 - 2.02) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.58 (1.22 - 2.03) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.62 (1.25 - 2.08) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.25 - 2.08) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.26 - 2.10) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.65 (1.27 - 2.11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
484 2016 Modelled WHO
193 (148 - 249) 1990 Modelled IHME, GBD 2019 (accessed 2022)
198 (153 - 255) 1991 Modelled IHME, GBD 2019 (accessed 2022)
204 (157 - 265) 1992 Modelled IHME, GBD 2019 (accessed 2022)
218 (167 - 282) 1994 Modelled IHME, GBD 2019 (accessed 2022)
213 (164 - 277) 1993 Modelled IHME, GBD 2019 (accessed 2022)
225 (173 - 292) 1995 Modelled IHME, GBD 2019 (accessed 2022)
229 (176 - 299) 1996 Modelled IHME, GBD 2019 (accessed 2022)
233 (180 - 301) 1997 Modelled IHME, GBD 2019 (accessed 2022)
239 (183 - 308) 1998 Modelled IHME, GBD 2019 (accessed 2022)
247 (191 - 320) 1999 Modelled IHME, GBD 2019 (accessed 2022)
254 (197 - 329) 2000 Modelled IHME, GBD 2019 (accessed 2022)
261 (201 - 338) 2001 Modelled IHME, GBD 2019 (accessed 2022)
271 (207 - 350) 2002 Modelled IHME, GBD 2019 (accessed 2022)
282 (216 - 365) 2003 Modelled IHME, GBD 2019 (accessed 2022)
272 (208 - 351) 2004 Modelled IHME, GBD 2019 (accessed 2022)
266 (204 - 344) 2005 Modelled IHME, GBD 2019 (accessed 2022)
264 (203 - 343) 2006 Modelled IHME, GBD 2019 (accessed 2022)
265 (204 - 338) 2008 Modelled IHME, GBD 2019 (accessed 2022)
262 (201 - 336) 2007 Modelled IHME, GBD 2019 (accessed 2022)
267 (205 - 337) 2009 Modelled IHME, GBD 2019 (accessed 2022)
268 (207 - 341) 2010 Modelled IHME, GBD 2019 (accessed 2022)
268 (206 - 342) 2011 Modelled IHME, GBD 2019 (accessed 2022)
270 (208 - 345) 2012 Modelled IHME, GBD 2019 (accessed 2022)
265 (205 - 339) 2013 Modelled IHME, GBD 2019 (accessed 2022)
262 (202 - 335) 2014 Modelled IHME, GBD 2019 (accessed 2022)
276 (212 - 353) 2016 Modelled IHME, GBD 2019 (accessed 2022)
268 (206 - 343) 2015 Modelled IHME, GBD 2019 (accessed 2022)
279 (213 - 355) 2017 Modelled IHME, GBD 2019 (accessed 2022)
281 (216 - 359) 2018 Modelled IHME, GBD 2019 (accessed 2022)
283 (218 - 362) 2019 Modelled IHME, GBD 2019 (accessed 2022)
283 (218 - 362) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (4 - 10) 2019 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
92 2019 Survey/reported WHO/UNICEF
93 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
414 (170 - 659) 2014 Survey/reported van Laar M et al, 2014
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.1 (0 - 0.20) 2015 Modelled Blach et al, 2017
0.52 (0.43 - 0.63) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.42 - 0.62) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.42 - 0.62) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.41 - 0.61) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.40 - 0.60) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.39 - 0.57) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.35 - 0.51) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.38 (0.31 - 0.46) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.28 - 0.41) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.27 - 0.39) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.27 - 0.39) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.28 - 0.39) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.28 - 0.40) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.35 (0.29 - 0.41) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.30 - 0.42) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.46) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.37 - 0.54) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.42 - 0.62) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.46 - 0.70) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.47 - 0.73) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.46 - 0.70) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.44 - 0.66) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.41 - 0.61) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.36 - 0.55) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.36 - 0.54) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.36 - 0.54) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.35 - 0.53) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.35 - 0.53) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.35 - 0.53) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.40 - 0.59) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.08 (0.03 - 0.13) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.16 (0.06 - 0.27) 2019 Survey/reported Koopsen J et al, 2019
0.1 (0 - 0.20) 2007 Survey/reported Vriend HJ et al, 2013
0.2 (0.10 - 0.40) 2014 Survey/reported Gower et al, 2014
0.22 2019 Modelled Jin et al. 2017
0.1 (0 - 0.20) 2007 Survey/reported ECDC
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
8.2 (5.10 - 12.10) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
55.3 (49.70 - 60.90) 2017 Modelled Degenhardt L et al, 2017
39.3 2013 Survey/reported EMCDDA
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
85.7 2017 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.3 (0.80 - 1.90) 2003 Survey/reported van de Laar TJ et al , 2007
0.7 (0.10 - 1.90) 2007 Survey/reported Van Rooijen MS et al , 2013
4.8 2017 Survey/reported ECDC
3.7 2019 Modelled Jin et al. 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
16,000 (5,000 - 26,000) 2015 Modelled Blach et al, 2017
59,544 (48,540 - 73,290) 1990 Modelled IHME, GBD 2019 (accessed 2022)
60,354 (49,254 - 74,182) 1991 Modelled IHME, GBD 2019 (accessed 2022)
61,252 (50,054 - 75,253) 1992 Modelled IHME, GBD 2019 (accessed 2022)
62,177 (50,899 - 76,173) 1993 Modelled IHME, GBD 2019 (accessed 2022)
63,127 (51,795 - 77,810) 1994 Modelled IHME, GBD 2019 (accessed 2022)
64,114 (52,386 - 78,743) 1995 Modelled IHME, GBD 2019 (accessed 2022)
67,053 (54,836 - 81,833) 1996 Modelled IHME, GBD 2019 (accessed 2022)
72,774 (59,186 - 88,532) 1997 Modelled IHME, GBD 2019 (accessed 2022)
79,468 (64,510 - 96,772) 1998 Modelled IHME, GBD 2019 (accessed 2022)
85,268 (68,744 - 104,341) 1999 Modelled IHME, GBD 2019 (accessed 2022)
88,258 (70,121 - 108,616) 2000 Modelled IHME, GBD 2019 (accessed 2022)
85,670 (69,307 - 104,064) 2001 Modelled IHME, GBD 2019 (accessed 2022)
78,015 (64,084 - 94,071) 2002 Modelled IHME, GBD 2019 (accessed 2022)
68,191 (56,474 - 81,496) 2003 Modelled IHME, GBD 2019 (accessed 2022)
59,316 (49,630 - 70,390) 2004 Modelled IHME, GBD 2019 (accessed 2022)
54,616 (45,611 - 64,881) 2005 Modelled IHME, GBD 2019 (accessed 2022)
53,163 (44,366 - 63,083) 2006 Modelled IHME, GBD 2019 (accessed 2022)
51,943 (43,214 - 61,570) 2007 Modelled IHME, GBD 2019 (accessed 2022)
51,041 (42,427 - 60,699) 2008 Modelled IHME, GBD 2019 (accessed 2022)
50,585 (41,733 - 60,410) 2009 Modelled IHME, GBD 2019 (accessed 2022)
50,706 (41,670 - 60,833) 2010 Modelled IHME, GBD 2019 (accessed 2022)
53,543 (43,766 - 64,133) 2011 Modelled IHME, GBD 2019 (accessed 2022)
59,887 (49,091 - 71,650) 2012 Modelled IHME, GBD 2019 (accessed 2022)
67,659 (55,665 - 80,855) 2013 Modelled IHME, GBD 2019 (accessed 2022)
74,738 (61,395 - 89,890) 2014 Modelled IHME, GBD 2019 (accessed 2022)
78,868 (64,381 - 95,391) 2015 Modelled IHME, GBD 2019 (accessed 2022)
80,464 (66,195 - 96,891) 2016 Modelled IHME, GBD 2019 (accessed 2022)
81,675 (67,073 - 99,250) 2017 Modelled IHME, GBD 2019 (accessed 2022)
82,731 (68,211 - 100,472) 2018 Modelled IHME, GBD 2019 (accessed 2022)
83,699 (68,826 - 102,169) 2019 Modelled IHME, GBD 2019 (accessed 2022)
82,650 (67,911 - 101,039) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
3,000 (940 - 4,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
3.62 (2.86 - 4.43) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.23 (1.77 - 2.78) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.86 - 2.91) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.27 (1.81 - 2.83) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.95 - 3.05) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.92 - 3) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (2.01 - 3.14) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (2.05 - 3.17) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.09 - 3.22) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.66 (2.12 - 3.29) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.73 (2.17 - 3.39) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.78 (2.21 - 3.50) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.33 - 3.65) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.27 - 3.56) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.04 (2.41 - 3.77) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.33 - 3.66) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.30 - 3.59) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.9 (2.29 - 3.60) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.96 (2.37 - 3.63) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.33 - 3.58) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.99 (2.38 - 3.67) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.40 - 3.72) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.09 (2.46 - 3.81) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.2 (2.57 - 3.95) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.24 (2.58 - 3.99) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.4 (2.69 - 4.19) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.29 (2.59 - 4.05) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.80 - 4.29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (2.76 - 4.31) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (2.81 - 4.36) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.62 (2.86 - 4.43) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
634 2016 Modelled WHO
621 (491 - 760) 2019 Modelled IHME, GBD 2019 (accessed 2022)
621 (491 - 760) 2019 Modelled IHME, GBD 2019 (accessed 2020)
609 (480 - 746) 2018 Modelled IHME, GBD 2019 (accessed 2022)
599 (471 - 734) 2017 Modelled IHME, GBD 2019 (accessed 2022)
595 (476 - 728) 2016 Modelled IHME, GBD 2019 (accessed 2022)
575 (455 - 708) 2015 Modelled IHME, GBD 2019 (accessed 2022)
554 (437 - 683) 2014 Modelled IHME, GBD 2019 (accessed 2022)
543 (433 - 670) 2013 Modelled IHME, GBD 2019 (accessed 2022)
535 (430 - 661) 2012 Modelled IHME, GBD 2019 (accessed 2022)
516 (410 - 635) 2011 Modelled IHME, GBD 2019 (accessed 2022)
503 (398 - 618) 2010 Modelled IHME, GBD 2019 (accessed 2022)
495 (394 - 607) 2009 Modelled IHME, GBD 2019 (accessed 2022)
487 (391 - 598) 2008 Modelled IHME, GBD 2019 (accessed 2022)
478 (382 - 587) 2007 Modelled IHME, GBD 2019 (accessed 2022)
476 (377 - 587) 2006 Modelled IHME, GBD 2019 (accessed 2022)
473 (373 - 587) 2005 Modelled IHME, GBD 2019 (accessed 2022)
479 (378 - 594) 2004 Modelled IHME, GBD 2019 (accessed 2022)
492 (389 - 609) 2003 Modelled IHME, GBD 2019 (accessed 2022)
474 (375 - 586) 2002 Modelled IHME, GBD 2019 (accessed 2022)
456 (363 - 569) 2001 Modelled IHME, GBD 2019 (accessed 2022)
442 (351 - 556) 2000 Modelled IHME, GBD 2019 (accessed 2022)
431 (343 - 536) 1999 Modelled IHME, GBD 2019 (accessed 2022)
417 (333 - 516) 1998 Modelled IHME, GBD 2019 (accessed 2022)
407 (326 - 502) 1997 Modelled IHME, GBD 2019 (accessed 2022)
398 (317 - 492) 1996 Modelled IHME, GBD 2019 (accessed 2022)
390 (311 - 484) 1995 Modelled IHME, GBD 2019 (accessed 2022)
376 (299 - 467) 1994 Modelled IHME, GBD 2019 (accessed 2022)
368 (292 - 457) 1993 Modelled IHME, GBD 2019 (accessed 2022)
352 (281 - 441) 1992 Modelled IHME, GBD 2019 (accessed 2022)
342 (272 - 426) 1991 Modelled IHME, GBD 2019 (accessed 2022)
332 (264 - 415) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
7 (5 - 9) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 11) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 11) 1995 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 1999 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 2000 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 17) 2006 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 20) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2007 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 22) 2010 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 2011 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 24) 2012 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 25) 2013 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 26) 2014 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2015 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 27) 2016 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2017 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2018 Modelled IHME, GBD 2019 (accessed 2022)
21 (15 - 27) 2019 Modelled IHME, GBD 2019 (accessed 2022)
35 (27 - 44) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
414 (170 - 659) 2014 Survey/reported van Laar M et al, 2014
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.94 (%)
2019
(0.77 - 1.13(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.48 (%)
2019
(0.4 - 0.59(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HBV (HBsAg+)
0.34 (%)
2016
(0.22 - 0.47(%))
Koopsen J et al, 2019
HCV (anti-HCV)
0.16 (%)
2019
(0.06 - 0.27(%))
Koopsen J et al, 2019

Hepatitis related deaths (national)

Modelled

HBV
283
2019
(218 - 362)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
621
2019
(491 - 760)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.08 (%)
2020, latest modelled
(0.07 - 0.09(%))
WHO

Prevalence PWID

HCV
39.30 (%)
2013, survey/surveillance
EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
414
2014
(170 - 659)
van Laar M et al, 2014
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all

News

Action plans

Resources